checkAd

     121  0 Kommentare TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update - Seite 4

    For more information, please contact:

    Lesen Sie auch

    TransCode Therapeutics, Inc.
    Alan Freidman, VP Investor Relations
    alan.freidman@transcodetherapeutics.com



    globenewswire
    0 Follower
    Autor folgen
    Seite 4 von 4

    Verfasst von globenewswire
    TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update - Seite 4 BOSTON, Nov. 14, 2023 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for the third quarter ended …